Med City News -- BridgePoint Medical Inc. has raised $9.1 million from the sale of equity, according to documents filed with the Securities and Exchange Commission. The company based in Plymouth, Minnesota, is developing balloon catheter system to treat chronic coronary and peripheral total occlusions, a condition in which clots frequently clog blood vessels.
